tirzepatide updates today Preliminary results on the monotherapy in Wolfram syndrome trial - Virtual Global Research and Trial Update from Big Easy on

References Souto-Miranda S, et al

long-term safety and efficacy data are not yet available

SURMOUNT-1 showed mean weight loss of 20.9% on the 15 mg dose

While research is still emerging on the relationships between GLP-1 medications and birth control, fertility, and pregnancy, manufacturers of these popular weight-loss drugs have provided recommendations for women who are currently taking oral contraceptives to avoid pregnancy

The high specificity of peptide-receptor interactions often results in fewer off-target effects compared to small molecule drugs

Until then, retatrutide appears more potent but tirzepatide is proven, approved, and available now via the tirzepatide dosage chart in units